Darius Moradpour

Q: What Schools Are Affiliated With Darius Moradpour

Darius Moradpour is affiliated with the following schools: Harvard University, University of Lausanne, University of California, Berkeley, University of Freiburg, Rockefeller University, Stanford University

Darius Moradpour's AcademicInfluence.com Rankings

Darius Moradpour

Computer Science

#7631

World Rank

#8034

Historical Rank

Computational Linguistics

#1558

World Rank

#1575

Historical Rank

Machine Learning

#2880

World Rank

#2916

Historical Rank

Artificial Intelligence

#3174

World Rank

#3221

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Darius Moradpour's Degrees

Masters Artificial Intelligence Stanford University
Bachelors Computer Science University of California, Berkeley

Similar Degrees You Can Earn

Why Is Darius Moradpour Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Darius Moradpour's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus (2005) (2398)
EASL Clinical Practice Guidelines: management of chronic hepatitis B. (2009) (1471)
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. (2010) (1216)
Expression of Hepatitis C Virus Proteins Induces Distinct Membrane Alterations Including a Candidate Viral Replication Complex (2002) (943)
EASL Clinical Practice Guidelines: Wilson's disease. (2012) (747)
Replication of hepatitis C virus (2007) (710)
Identification of the Hepatitis C Virus RNA Replication Complex in Huh-7 Cells Harboring Subgenomic Replicons (2003) (696)
In vivo gene electroinjection and expression in rat liver (1996) (427)
Structural biology of hepatitis C virus (2004) (415)
An Amino-terminal Amphipathic α-Helix Mediates Membrane Association of the Hepatitis C Virus Nonstructural Protein 5A* (2002) (387)
Subcellular Localization, Stability, andtrans-Cleavage Competence of the Hepatitis C Virus NS3-NS4A Complex Expressed in Tetracycline-Regulated Cell Lines (2000) (340)
Structural biology of hepatitis C virus. (2003) (333)
EASL Clinical Practice Guidelines on hepatitis E virus infection. (2018) (329)
Expression of Hepatitis C Virus Proteins Inhibits Signal Transduction through the Jak-STAT Pathway (1999) (313)
Structure and Function of the Membrane Anchor Domain of Hepatitis C Virus Nonstructural Protein 5A* (2004) (305)
Insertion of Green Fluorescent Protein into Nonstructural Protein 5A Allows Direct Visualization of Functional Hepatitis C Virus Replication Complexes (2004) (286)
Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C. (2009) (286)
Hepatitis C virus proteins: from structure to function. (2013) (283)
The Native Form and Maturation Process of Hepatitis C Virus Core Protein (1998) (269)
The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein. (2001) (266)
Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. (1996) (251)
Determinants for Membrane Association of the Hepatitis C Virus RNA-dependent RNA Polymerase* (2001) (244)
IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction (2013) (214)
Interferon-α inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway (2001) (206)
Structural and Functional Studies of Nonstructural Protein 2 of the Hepatitis C Virus Reveal Its Key Role as Organizer of Virion Assembly (2010) (202)
Expression of hepatitis c virus proteins inhibits interferon alpha signaling in the liver of transgenic mice. (2003) (190)
[Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]. (2018) (185)
Membrane Association of the RNA-Dependent RNA Polymerase Is Essential for Hepatitis C Virus RNA Replication (2004) (181)
Pathogenesis of hepatocellular carcinoma. (2005) (177)
NS2 Protein of Hepatitis C Virus Interacts with Structural and Non-Structural Proteins towards Virus Assembly (2011) (177)
Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin. (2016) (168)
Update on hepatitis E virology: Implications for clinical practice. (2016) (168)
[Management of chronic hepatitis B]. (2010) (167)
Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins (1998) (163)
Membrane association of hepatitis C virus nonstructural proteins and identification of the membrane alteration that harbors the viral replication complex. (2003) (162)
Interaction of hepatitis C virus proteins with host cell membranes and lipids. (2002) (159)
Nonstructural protein 3‐4A: the Swiss army knife of hepatitis C virus (2011) (158)
Hepatitis B and C virus coinfection: A novel model system reveals the absence of direct viral interference (2009) (158)
Hepatitis C Virus Glycoprotein Complex Localization in the Endoplasmic Reticulum Involves a Determinant for Retention and Not Retrieval* (1998) (158)
Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection. (2012) (155)
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non‐1 HCV genotypes (2012) (153)
euHCVdb: the European hepatitis C virus database (2006) (149)
Hepatitis C Virus-Linked Mitochondrial Dysfunction Promotes Hypoxia-Inducible Factor 1α-Mediated Glycolytic Adaptation (2009) (147)
A Dynamic View of Hepatitis C Virus Replication Complexes (2008) (146)
Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complex (2008) (138)
Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon‐sensitive virus replication (1999) (137)
Expression of Hepatitis C Virus Proteins Interferes with the Antiviral Action of Interferon Independently of PKR-Mediated Control of Protein Synthesis (2000) (136)
NS4B Self-Interaction through Conserved C-Terminal Elements Is Required for the Establishment of Functional Hepatitis C Virus Replication Complexes (2011) (136)
Hepatitis E Virus Seroprevalence and Chronic Infections in Patients with HIV, Switzerland (2011) (131)
Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection. (2011) (126)
Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system (2010) (124)
Hepatitis C virus protein expression causes calcium‐mediated mitochondrial bioenergetic dysfunction and nitro‐oxidative stress (2007) (124)
Hepatitis C virus nonstructural protein 4B: a journey into unexplored territory (2010) (124)
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes (2014) (123)
[Molecular virology of hepatitis C]. (2002) (122)
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies. (2018) (117)
The Hepatitis C Virus RNA-Dependent RNA Polymerase Membrane Insertion Sequence Is a Transmembrane Segment (2002) (117)
Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis. (2011) (114)
Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5). (2016) (110)
Chlorpromazine‐induced vanishing bile duct syndrome leading to biliary cirrhosis (1994) (110)
GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer (2014) (108)
Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. (2001) (105)
Hepatitis E Virus Seroprevalence among Blood Donors in Southwest Switzerland (2011) (103)
Identification of a Novel Determinant for Membrane Association in Hepatitis C Virus Nonstructural Protein 4B (2009) (98)
Impact of common risk factors of fibrosis progression in chronic hepatitis C (2014) (96)
Expression and immune response to hepatitis C virus core DNA–based vaccine constructs (1996) (95)
Molecular Virology of Hepatitis C Virus (HCV): 2006 Update (2006) (92)
Upregulation of Protein Phosphatase 2Ac by Hepatitis C Virus Modulates NS3 Helicase Activity through Inhibition of Protein Arginine Methyltransferase 1 (2005) (92)
Amphipathic α-Helix AH2 Is a Major Determinant for the Oligomerization of Hepatitis C Virus Nonstructural Protein 4B (2010) (84)
Acromegaly caused by secretion of growth hormone by a non-Hodgkin's lymphoma. (2000) (82)
Hepatitis delta-associated mortality in HIV/HBV-coinfected patients. (2017) (80)
Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study (2018) (78)
Hepatitis C Virus Infection and Kidney Transplantation in 2014: What's New? (2014) (77)
An Amphipathic α-Helix at the C Terminus of Hepatitis C Virus Nonstructural Protein 4B Mediates Membrane Association (2009) (75)
Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma. (2013) (75)
Gene therapy for chronic viral hepatitis: Ribozymes, antisense oligonucleotides, and dominant negative mutants (1997) (72)
Liver‐directed gene transfer: a linear polyethylenimine derivative mediates highly efficient DNA delivery to primary hepatocytes in vitro and in vivo (1998) (70)
Early transjugular intrahepatic portosystemic shunt in cirrhotic patients with acute variceal bleeding: a systematic review and meta-analysis of controlled trials (2015) (69)
Novel Approach Identifies SNPs in SLC2A10 and KCNK9 with Evidence for Parent-of-Origin Effect on Body Mass Index (2014) (69)
Clinical phenotype and outcome of hepatitis E virus–associated neuralgic amyotrophy (2017) (64)
HCV infection induces mitochondrial bioenergetic unbalance: causes and effects. (2009) (63)
Genetic Analyses Reveal a Role for Vitamin D Insufficiency in HCV-Associated Hepatocellular Carcinoma Development (2013) (62)
A Genetic Validation Study Reveals a Role of Vitamin D Metabolism in the Response to Interferon-Alfa-Based Therapy of Chronic Hepatitis C (2012) (62)
Hepatitis C virus infection in haemodialysis and kidney transplant patients (2008) (61)
Cytotoxic T Lymphocytes Derived from Patients with Chronic Hepatitis C Virus Infection Kill Bystander Cells via Fas-FasL Interaction (2004) (61)
[DNA vaccination]. (2000) (60)
Correction: Corrigendum: Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes (2014) (59)
Hepatitis C: molecular virology and antiviral targets. (2002) (58)
Characterization of three novel monoclonal antibodies against hepatitis C virus core protein (1996) (57)
Functional Properties of a Monoclonal Antibody Inhibiting the Hepatitis C Virus RNA-dependent RNA Polymerase* (2002) (56)
An Analysis of the Benefit of Using HEV Genotype 3 Antigens in Detecting Anti-HEV IgG in a European Population (2013) (55)
NMR structure and molecular dynamics of the in-plane membrane anchor of nonstructural protein 5A from bovine viral diarrhea virus. (2006) (54)
The cyclophilin inhibitor alisporivir prevents hepatitis C virus–mediated mitochondrial dysfunction (2012) (52)
Vitamin D Receptor and Jak–STAT Signaling Crosstalk Results in Calcitriol-Mediated Increase of Hepatocellular Response to IFN-α (2014) (51)
A liposomal peptide vaccine inducing CD8+ T cells in HLA-A2.1 transgenic mice, which recognise human cells encoding hepatitis C virus (HCV) proteins. (2004) (50)
Palmitoylation mediates membrane association of hepatitis E virus ORF3 protein and is required for infectious particle secretion (2018) (50)
Understanding hepatitis B virus infection. (1995) (49)
Tuberculous colitis mimicking Crohn's disease (1998) (49)
Aminoterminal Amphipathic α-Helix AH1 of Hepatitis C Virus Nonstructural Protein 4B Possesses a Dual Role in RNA Replication and Virus Production (2014) (49)
Analysis of hepatitis C virus resistance to silibinin in vitro and in vivo points to a novel mechanism involving nonstructural protein 4B (2013) (47)
Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon‐alpha and ribavirin therapy (2012) (47)
Viral pathogenesis of hepatocellular carcinoma (2002) (47)
Function follows form: The structure of the N‐terminal domain of HCV NS5A (2005) (47)
Efficient gene transfer into mammalian cells with cholesteryl-spermidine. (1996) (45)
Systematic review with meta‐analysis: self‐expanding metal stents in patients with cirrhosis and severe or refractory oesophageal variceal bleeding (2015) (45)
Visualization of hepatitis E virus RNA and proteins in the human liver. (2017) (45)
Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up (2017) (44)
Rabbit HEV in immunosuppressed patients with hepatitis E acquired in Switzerland. (2019) (44)
Current and evolving therapies for hepatitis C. (1999) (42)
[Eosinophilic gastrointestinal disorders]. (2016) (42)
Conserved Determinants for Membrane Association of Nonstructural Protein 5A fromHepatitis C Virus and Related Viruses (2006) (41)
Hemostatic Alterations in Patients With Cirrhosis: From Primary Hemostasis to Fibrinolysis (2020) (40)
[DNA chip technology]. (1999) (40)
Quantitative proteomics identifies the membrane‐associated peroxidase GPx8 as a cellular substrate of the hepatitis C virus NS3‐4A protease (2014) (40)
Tightly regulated expression of the entire hepatitis C virus structural region in continuous human cell lines. (1998) (40)
Targeted gene transfer to hepatocellular carcinoma cells in vitro using a novel monoclonal antibody−based gene delivery system (1999) (39)
Pan-Genotype Hepatitis E Virus Replication in Stem Cell-Derived Hepatocellular Systems. (2017) (36)
Suppression of short interfering RNA-mediated gene silencing by the structural proteins of hepatitis C virus. (2008) (36)
Prevalence of anti‐HLA antibodies after liver transplantation (2009) (35)
Comparison between cytomegalovirus promoter and elongation factor-1 alpha promoter-driven constructs in the establishment of cell lines expressing hepatitis C virus core protein. (1997) (35)
Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection. (2013) (35)
Expression of hepatitis C virus proteins does not interfere with major histocompatibility complex class I processing and presentation in vitro (2001) (34)
A systematic review and meta‐analysis of HCV clearance (2017) (32)
Specific targeting of human hepatocellular carcinoma cells by immunoliposomes in vitro (1995) (31)
A primer on the molecular virology of hepatitis C (2004) (31)
Antiviral effects of antisense RNA on hepatitis C virus RNA translation and expression (1999) (27)
Recombinant Hepatitis E Viruses Harboring Tags in the ORF1 Protein (2019) (26)
Targeting mitochondria in the infection strategy of the hepatitis C virus. (2013) (26)
Future landscape of hepatitis C research - Basic, translational and clinical perspectives. (2016) (25)
Structure and Function of the Membrane Anchor Domain of Hepatitis C Virus Nonstructural Protein 5 A (2004) (25)
A European survey of perendoscopic treatment of biliary complications in patients with alveolar echinococcosis (2017) (25)
Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus(HCV)-Infektion (2020) (25)
Neurologic complications of acute hepatitis E virus infection (2019) (24)
Cell-free expression, purification, and membrane reconstitution for NMR studies of the nonstructural protein 4B from hepatitis C virus (2016) (24)
Identification of GBF1 as a cellular factor required for hepatitis E virus RNA replication (2017) (23)
Multiplex Liquid Chromatography-Tandem Mass Spectrometry Assay for Simultaneous Therapeutic Drug Monitoring of Ribavirin, Boceprevir, and Telaprevir (2013) (23)
GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer (2014) (23)
Hepatitis E virus as a cause of acute hepatitis acquired in Switzerland (2017) (23)
[An update on the management of chronic hepatitis C]. (2010) (22)
Identification of Naturally Processed Hepatitis C Virus-Derived Major Histocompatibility Complex Class I Ligands (2012) (22)
Wheat germ cell-free expression: Two detergents with a low critical micelle concentration allow for production of soluble HCV membrane proteins. (2015) (22)
Hepatitis E virus infection as a direct cause of neuralgic amyotrophy (2016) (22)
Hepatitis C virus infection: in vivo and in vitro models (2007) (21)
Absence of hepatitis delta infection in a large rural HIV cohort in Tanzania. (2016) (20)
Bridging basic science and clinical research: the EASL Monothematic Conference on Translational Research in Viral Hepatitis. (2014) (20)
The molecular pathogenesis of hepatocellular carcinoma (1994) (19)
Isolation and characterization of human monoclonal antibodies against hepatitis C virus envelope glycoproteins (1998) (19)
Hepatitis C Virus RNA Replication Requires a Conserved Structural Motif within the Transmembrane Domain of the NS5B RNA-Dependent RNA Polymerase (2010) (19)
Sofosbuvir add-on to ribavirin for chronic hepatitis E in a cirrhotic liver transplant recipient: a case report (2019) (18)
New insights into hepatitis B and C virus co-infection. (2009) (18)
Immunosuppression in hepatitis C virus-infected patients after kidney transplantation. (2012) (17)
Impact of Tenofovir on Hepatitis Delta Virus Replication in the Swiss Human Immunodeficiency Virus Cohort Study (2017) (17)
Elderly age is not a negative predictive factor for virological response to therapy with pegylated interferon‐α and ribavirin in chronic hepatitis C virus patients (2014) (17)
Determinants for Membrane Association of the Hepatitis C Virus NS2 Protease Domain (2014) (17)
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma. (2012) (16)
Hepatitis C update (2001) (16)
Human transmissible spongiform encephalopathies. (1998) (16)
Acute immune thrombocytopaenic purpura in a patient with COVID-19 and decompensated cirrhosis (2020) (16)
Immunological approach to hepatocellular carcinoma (1997) (16)
Effect of antiviral therapy on circulating cytokeratin‐18 fragments in patients with chronic hepatitis C (2010) (16)
Genomic determinants of the efficiency of internal ribosomal entry sites of viral and cellular origin (2008) (15)
Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection (2012) (15)
Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection (2012) (15)
Targeting Endoplasmic Reticulum and/or Mitochondrial Ca2+ Fluxes as Therapeutic Strategy for HCV Infection (2018) (14)
An Aminoterminal Amphipathic-Helix Mediates Membrane Association of the Hepatitis C Virus Nonstructural Protein 5 A (2001) (14)
Trends in hepatitis C‐related mortality in Switzerland (2018) (14)
Protective role of amantadine in mitochondrial dysfunction and oxidative stress mediated by hepatitis C virus protein expression. (2014) (14)
A fresh look at interferon‐α signaling and treatment outcomes in chronic hepatitis C (2008) (13)
Very low hepatitis C viral loads in treatment-naïve persons: do they compromise hepatitis C virus antigen testing? (2019) (13)
[Therapy of chronic hepatitis C]. (2006) (13)
Very low hepatitis C viral loads in treatment-naïve persons: do they compromise hepatitis C virus antigen testing? (2019) (13)
Characterization of Nonstructural Protein Membrane Anchor Deletion Mutants Expressed in the Context of the Hepatitis C Virus Polyprotein (2005) (13)
Biomarkers of liver dysfunction correlate with a prothrombotic and not with a prohaemorrhagic profile in patients with cirrhosis (2020) (13)
Glycogen Synthase Kinase 3β Enhances Hepatitis C Virus Replication by Supporting miR-122 (2018) (12)
Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 Infections. (2019) (12)
On the Host Side of the Hepatitis E Virus Life Cycle (2020) (12)
Enhanced Gene Delivery and Expression in Human Hepatocellular Carcinoma Cells by Cationic Immunoliposomes (1997) (12)
Therapie der chronischen Hepatitis C (2005) (12)
The histologic presentation of hepatitis E reflects patients’ immune status and pre-existing liver condition (2020) (11)
Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agents. (2019) (11)
BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease (2016) (11)
Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-β induction by efficient MAVS cleavage. (2015) (11)
Hepatocellular type II fibrinogen inclusions in a patient with severe COVID-19 and hepatitis (2020) (11)
Injection drug use before and after liver transplantation: a retrospective multicenter analysis on incidence and outcome (2010) (10)
Resistance‐associated substitutions in patients with chronic hepatitis C virus genotype 4 infection (2020) (10)
NS2 Proteins of GB Virus B and Hepatitis C Virus Share Common Protease Activities and Membrane Topologies (2014) (10)
Late hepatitis B reactivation following direct‐acting antiviral–based treatment of recurrent hepatitis C in an anti‐HBc–positive liver transplant recipient (2018) (10)
the Swiss Hepatitis C Cohort Study Group (2011) (9)
Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening Recommendations (2016) (9)
Investigation of the hepatitis C virus replication complex. (2009) (8)
Independent regulation of two separate gene activities in a continuous human cell line. (1998) (8)
Therapeutic drug monitoring for sofosbuvir and daclatasvir in transplant recipients with chronic hepatitis C and advanced renal disease. (2016) (8)
Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir. (2012) (8)
Review article: HCV ? STAT-C era of therapy (2010) (8)
Hepatic manifestations of Wilson's disease: 12-year experience in a Swiss tertiary referral centre. (2018) (8)
Differential modulation of hepatitis C virus replication and innate immune pathways by synthetic calcitriol-analogs (2018) (8)
Combined Lung and Liver Transplantation for Short Telomere Syndrome (2020) (7)
Management of Severe Portopulmonary Hypertension With Dual Oral Therapy Before Liver Transplantation. (2018) (7)
Hepatitis C virus comes full circle: Production of recombinant infectious virus in tissue culture (2005) (7)
Clinical Significance of the CCR5delta32 Allele in Hepatitis C (2014) (7)
[Hepatitis C: epidemiology natural course and diagnosis]. (2015) (7)
Ligand-mediated retargeting of recombinant adenovirus for gene transfer in vivo (2000) (7)
Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management (2021) (7)
LP54 : Sofosbuvir inhibits hepatitis E virus replication in vitro and results in an additive effect when combined with ribavirin (2015) (7)
[Hepatitis B virus mutants--clinical significance]. (1997) (7)
Recent developments in target identification against hepatitis C virus (2004) (7)
A model for the study of hepatitis C virus entry (2003) (6)
[Diagnosis of hepatitis B and C]. (2005) (6)
Combined antiviral therapy for recurrent hepatitis C virus after liver transplantation. (2007) (6)
Optimizing Ribavirin Exposure by Therapeutic Drug Monitoring Improves Treatment Response in Patients With Chronic Hepatitis C Genotype 1 (2013) (6)
Treatment of chronic hepatitis E with ribavirin: lessons from deep sequencing (2016) (6)
CLINICAL ADVANCES IN LIVER, PANCREAS, AND BILIARY TRACT Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study (2010) (5)
Of mice and men: A small animal model of hepatitis C virus replication (2002) (5)
Reading between the lines: Evidence for a new hepatitis C virus protein (2002) (5)
Oral valganciclovir for cytomegalovirus colitis after liver transplantation. (2007) (5)
Surprises from the crystal structure of the hepatitis C virus NS2‐3 protease (2006) (5)
[Management of chronic viral hepatitis]. (2007) (5)
Access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study: a person‐centred approach (2016) (5)
Stable human lymphoblastoid cell lines constitutively expressing hepatitis C virus proteins. (2005) (5)
Hepatitis C: a concise review. (2001) (4)
Lower Risk of B1-to-pB3-Stage Migration in Crohn’s Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study (2019) (4)
Progress in Understanding the Pathogenesis of Nonalcoholic Fatty Liver Disease (2004) (4)
Hepatitis B und C: von der molekularen Virologie zu neuen Perspektiven in der Therapie (2014) (4)
Hepatitis E virus finds its path through the gut (2020) (4)
Human genomics of acute liver failure due to hepatitis B virus infection: an exome sequencing study in liver transplant recipients (2018) (4)
OCIAD1 is a host mitochondrial substrate of the hepatitis C virus NS3-4A protease (2020) (4)
Cell lines that allow regulated expression of HCV proteins: principles and applications (2003) (4)
544 A EUROPEAN FIELD STUDY OF THE EFFICACY AND SAFETY OF TENOFOVIR DISOPROXIL FUMARATE (TDF) AS MONOTHERAPY IN PATIENTS WITH PRIOR FAILURE TO OTHER NUCLEOSIDE/NUCLEOTIDE ANALOGUES (2012) (4)
Chapter 8 – Replication and Pathogenesis of Hepatitis C Virus (2006) (4)
Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction (2022) (4)
[New hepatitis C treatments: pharmacological considerations and potential for drug interactions]. (2014) (4)
Trends in hepatitis C-related mortality in Switzerland (2017) (4)
[Outpatient follow-up of liver transplant recipients: the essential role of the general practitioner]. (2019) (4)
Hepatitis E virus RNA‐dependent RNA polymerase is involved in RNA replication and infectious particle production (2021) (3)
All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS) (2020) (3)
Consequences of the multipatient use of a single-patient capillary blood sampling device (CBSD) (2011) (3)
NATURAL COURSE OF HBV INFECTION (1998) (3)
[Hepatitis B and C: from molecular virology to new antiviral therapies (part 2)]. (2014) (3)
1401 GENOME-WIDE ASSOCIATION STUDY IDENTIFIES VARIANTS ASSOCIATED WITH LIVER FIBROSIS PROGRESSION IN HCV-INFECTED PATIENTS (2012) (3)
Uncontrolled hepatitis delta virus infection after initial suppression on tenofovir in a HIV/HBV-coinfected patient. (2016) (3)
[An update on hepatitis E]. (2013) (3)
Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events (2022) (3)
Successful heart and liver transplantation in a Swiss patient with Glu89Lys transthyretin amyloidosis. (2011) (3)
[Hepatitis B and C: From molecular virology to new antiviral therapies (part 1)]. (2014) (3)
BRIP 1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV-or HBV-related liver disease (2019) (3)
Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center (2021) (3)
Hepatology highlights: Viral hepatitis (2004) (3)
[Disseminated toxoplasmosis in AIDS]. (1993) (3)
Disseminierte Toxoplasmose bei AIDS (2008) (3)
Clinical phenotype and outcome of hepatitis E virus associated neuralgic amyotrophy; an international retrospective comparative cohort study (2017) (3)
1361 IL28B POLYMORPHISMS LINKED TO POOR RESPONSE TO TREATMENT ARE ASSOCIATED WITH LOW NECROINFLAMMATORY ACTIVITY AND SLOW FIBROSIS PROGRESSION IN HCV GENOTYPE NON-1-INFECTED PATIENTS (2011) (3)
A new twist to translation initiation of the hepatitis C virus (2002) (3)
[Clinical significance of hepatitis B virus mutants]. (1998) (3)
Rapid Remission of Graves' Hyperthyroidism Without Thionamides Under Immunosuppressive Treatment for Concomitant Autoimmune Hepatitis. (2018) (2)
Chasing the escape mutant (1993) (2)
[Liver transplantation: new organ allocation system in Switzerland]. (2008) (2)
Hepatitis C: aktuelle Therapie (2015) (2)
DIE PRIMAR-SKLEROSIERENDE CHOLANGITIS (2008) (2)
The promise of advanced imaging techniques for the detection of hepatitis C virus antigens in the infected liver. (2009) (2)
Hepatitis C virus proteins promote mitochondrial bioenergetic dysfunction and nitro-oxidative stress: insights into pathogenesis (2009) (2)
75: A variant of IFNλ4 displaying decreased activity is associated with better hepatitis C virus clearance and reduced ISG expression (2014) (2)
Sofosbuvir and ribavirin before liver re-transplantation for graft failure due to recurrent hepatitis C: a case report (2015) (2)
Effect of hepatitis B virus on steatosis in hepatitis C virus co‐infected subjects: A multi‐centre study and systematic review (2018) (2)
Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study (2019) (2)
A mouse model for hepatitis E virus infection. (2016) (2)
Case Report: SARS-CoV-2 as an unexpected causal agent of predominant febrile hepatitis (2021) (2)
[Nosebleed, vision disorders]. (1990) (2)
Le point sur le traitement de l'hépatite C chronique [An update on the management of chronic hepatitis C] (2010) (2)
[Complications of liver cirrhosis: oesophageal varices, ascites and hepato-cellular carcinoma]. (2005) (2)
Antisense oligonucleotide therapy of hepadnavirus infection. (2000) (1)
Treatment of Chronic Hepatitis C (2015) (1)
[Hepatitis C, diagnosis and therapy]. (1996) (1)
1419 IL28B RNA EXPRESSION DEPENDS ON A NOVEL TT/-G POLYMORPHISM ASSOCIATED WITH IMPROVED HCV CLEARANCE PREDICTION (2013) (1)
High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus. (2021) (1)
Antiviral treatment of patients with HBV‐related cirrhosis (2002) (1)
[Advances in gastroenterology and hepatology 2020]. (2021) (1)
Hepatitis G virus infection in Chinese patients with chronic hepatitis B, C or non-A-E: clinical and molecular aspects (1999) (1)
Impact of tenofovir on hepatitis delta virus replication in the Swiss HIV Cohort Study (2017) (1)
[Early TIPS: a practical review after 15 years of scientific evidence]. (2020) (1)
Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure. (2022) (1)
[Highlights in hepatology]. (2009) (1)
[Management of ascites due to portal hypertension]. (2012) (1)
[Molecular aspects of hepatocellular carcinoma]. (2000) (1)
P0683 : Hepatitis C virus NS3-4A protease targets the host factor BNIP1 at a non-canonical cleavage site (2015) (1)
Palmitoylation determines the subcellular localization of the hepatitis E virus ORF3 protein (2018) (1)
P701 AUTOCHTHONOUS ACUTE HEPATITIS E IN SWITZERLAND: INCREASED RATE OF SEVERE MANIFESTATION IN MEN >50 YEARS (2014) (1)
Hepatitis B und C: von der molekularen Virologie zu neuen Perspektiven in der Therapie (2014) (1)
Hépatitis C. Therapeutische Fortschritte (2012) (1)
Empfehlungen für die Nachsorge von Patientinnen/Patienten mit ausgeheilter Hepatitis C (2021) (1)
Hepatitis C: Epidemiologie, natürlicher Verlauf und Diagnostik (2015) (1)
Diagnostik der Hepatitis B und C (2005) (1)
[Management of hepatocellular carcinoma]. (2010) (1)
[Visceral leishmaniasis as an opportunistic infection. Case report and literature review]. (1990) (1)
1357 A LARGE-SCALE GENETIC VALIDATION STUDY COUPLED WITH IN-VITRO ANALYSES REVEAL A ROLE OF VITAMIN D-SIGNALING IN THE PATHOGENESIS AND TREATMENT OF CHRONIC HEPATITIS C (2011) (1)
TEMPORARY REMOVAL: Hepatitis A and E - differences and commonalities. (2020) (1)
[Primary biliary cholangitis : an update]. (2018) (1)
[Hepatitis C: current therapy]. (2015) (1)
Cholestase: Definition, Differentialdiagnose und laborchemische Diagnostik (1999) (1)
[Lipid-lowering treatment and liver dysfunction]. (2012) (1)
Structure and function of the membrane domain of hepatitis C virus nonstructural protein 5A (2004) (1)
[Auto-immune liver diseases and their treatment]. (2005) (1)
Sa1262 Long Diagnostic Delay in Crohn's Disease is Associated With Complicated Disease Course and Increased Operation Rate (2012) (1)
Sa1230 Frequency and Type of Side Effects of Immunomodulating Medication in the Swiss Inflammatory Bowel Disease Cohort (2012) (1)
Hypothyroidism, Congenital (2005) (1)
Identification of glycogen synthase kinase 3 beta as a novel host factor of hepatitis C virus replication (2017) (0)
[Progress and new challenges in hepatitis C]. (2013) (0)
Increasing prevalence of obesity and diabetes among patients evaluated for liver transplantation in a Swiss tertiary referral center: a 10-year retrospective analysis. (2022) (0)
Treatment of Chronic Hepatitis C - August 2017 Update (2017) (0)
[Highlights in gastroenterology and hepatology 2010]. (2011) (0)
123 A FUNCTIONAL LINK BETWEEN VITAMIN D RECEPTOR AND JAK-STAT SIGNALING RESULTS IN SYNERGISTIC HEPATOCELLULAR RESPONSE TO CALCITRIOL AND INTERFERON-α (2012) (0)
[New hepatitis viruses. Molecular biology and clinical aspects]. (1996) (0)
S12.13 Hepatitis C virus proteins cause calcium-mediated mitochondrial dysfunction and hif-linked bioenergetic compensatory adaptation (2008) (0)
[SARS-CoV-2 infection and solid organ transplantation]. (2020) (0)
417 EFFECT OF ANTIVIRAL THERAPY ON THE CIRCULATING LEVELS OF CYTOKERATIN-18 FRAGMENTS IN CHRONIC HEPATITIS C (2009) (0)
P0534 : Hepatitis E virus RNA replication is ensured by unprocessed ORF1 protein (2015) (0)
SARS-CoV-2 infection and solid organ transplantation/ Infection a SARS-CoV-2 et transplantation dorganes solides (2020) (0)
Short Communication Suppression of short interfering RNA-mediated gene silencing by the structural proteins of hepatitis C virus (2008) (0)
[Treatment of hepatitis: new ways, new hopes and new challenges]. (2007) (0)
Hepatitis c virus infection induces pro- and antiapoptotic cell response: who is the winner? (2010) (0)
Specific inhibition of hepatitis C virus gene expression by antisense oligonucleotides in a tightly regulated cell culture system (1995) (0)
Tu1172 Primary Sclerosing Cholangitis in the Swiss IBD Cohort Study: Prevalence, Patient Characteristics, and Disease Course (2013) (0)
[Molecular biology in internal medicine. Report of the 24th Ludwig Heilmeyer Symposium of the Society for Progress in Internal Medicine]. (1997) (0)
792 HBV-HCV COINFECTION: A NOVEL MODEL SYSTEM REVEALS INSIGHTS INTO IMMUNOLOGICAL MECHANISMS OF VIRAL INTERFERENCE (2012) (0)
Screening for Hepatitis C Virus (HCV) protein interactions by the use of intergenotypic replicon chimeras (2011) (0)
[Short telomere syndrome in adults: a rare entity that should be evoked]. (2022) (0)
DNA Chip-Technologie (2008) (0)
[The era of management of hepatitis c patients]. (2011) (0)
The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patients (2022) (0)
Histopathology of hepatitis E is associated with patients’ immune status and preexisting liver condition (2020) (0)
Strategies for Targeted Uptake of Antisense Oligonucleotides in Hepatocytes (1999) (0)
P660 THE EFFECT OH HEPATITIS B VIRUS INFECTION ON STEATOSIS IN HEPATITIS C VIRUS COINFECTED PATIENTS: THE BOSTIC STUDY (2014) (0)
[Hepatitis C: 25 years of progress with still major challenges]. (2015) (0)
Mechanisms of Interferon Resistance (2007) (0)
[Implication of mutation of hepatitis C virus 1b interferon sensitivity determining region(NS5A aa 2209-2248) response to interferon alpha therapy in patients with chronic hepatitis C]. (1999) (0)
802 CHARACTERIZATION OF A MAJOR V3 DUPLICATION IN THE NS5A REGION OF GENOTYPE IB HCV BY QUASISPECIES ANALYSIS IN A FRENCH MULTICENTER STUDY (2011) (0)
[Fecal calprotectin: a diagnostic tool for inflammatory bowel disease]. (2012) (0)
Recombinant drugs and gene therapy (1999) (0)
A genome-wide CRISPR/Cas9 screen identifies Rab5A as host factor of the hepatitis E virus life cycle (2022) (0)
[Coffee and the pancreas: a half life of medical truth]. (2014) (0)
[Maculopapular rash, pruritus, upper abdominal pain, attacks of dizziness]. (1991) (0)
[Transthyretin-related hereditary amyloidosis]. (2016) (0)
P0200 : Early transjugular intrahepatic portosystemic shunt in cirrhotic patients with acute variceal bleeding: A meta-analysis of controlled trials (2015) (0)
Hepatitis-B-Virusmutanten--klinische Bedeutung. [Hepatitis B virus mutants--clinical significance] (1997) (0)
Chronic hepatitis C: Portrait of a silent epidemic and the etiologic agent (2008) (0)
Amphipathic (cid:1) -Helix AH2 Is a Major Determinant for the Oligomerization of Hepatitis C Virus Nonstructural Protein 4B (cid:1) † (2010) (0)
Hépatite C: information pour les patients (2015) (0)
Effect of Hepatitis B virus on Steatosis in Hepatitis C virus co-infected subjects: a multi-center study and systematic review (0)
La transplantation hépatique (2011) (0)
[Gene technology drugs and gene therapy]. (1999) (0)
Expanding the Hepatitis E Virus Toolbox: Selectable Replicons and Recombinant Reporter Genomes (2023) (0)
[Hepatic encephalopathy: recent developments]. (2014) (0)
P196 INVESTIGATION OF HEPATITIS C VIRUS ADAPTATION TO HOST GENETIC POLYMORPHISMS (2014) (0)
[Painful knee, fever]. (1987) (0)
[Hepatocellular adenoma: update 2020]. (2020) (0)
[Recent progress in hepatology]. (2011) (0)
Edinburgh Research Explorer Novel Approach Identifies SNPs in SLC2A10 and KCNK9 with Evidence for Parent-of-Origin Effect on Body Mass Index (2017) (0)
Infection à SARS-CoV-2 et transplantation d’organes solides (2020) (0)
La transpantation hépatique. (2011) (0)
SAT-199-Recombinant hepatitis E viruses harbouring tags in the ORF1 protein allow visualisation of the viral replicase (2019) (0)
University of Groningen Novel approach identifies SNPs in SLC2A10 and KCNK9 with evidence for parent-of-origin effect on body mass index Hoggart, (2014) (0)
Evaluating the individual risk of venous thrombo-embolism in patients with liver cirrhosis: Usefulness of in vivo and ex vivo thrombin generation parameters (2023) (0)
Primary sclerosing cholangitis in the Swiss In fl ammatory Bowel Disease Cohort Study : prevalence , risk factors , and long-term follow-up (0)
[Hepatocellular carcinoma: a multidisciplinary approach]. (2005) (0)
Chapter 7 – Replication of Hepatitis C Virus (2012) (0)
[A primer on Wilson disease for the general practitioner]. (2011) (0)
Of mice and men - ein In-vivo-Modell der Hepatitis-C-Virus-Replikation (2002) (0)
Chronic hepatitis C: portrait of a silent epidemic. (2008) (0)
NMR structure of the in-plane membrane anchor domain [1-28] of the monotopic NonStructural Protein 5A (NS5A) from the Bovine Viral Diarrhea Virus (BVDV) (2005) (0)
Expression and immune response to hepatitis C virus DNA vaccine constructs (1995) (0)
[Alagille Syndrome]. (2019) (0)
Biochemical Characterization of Hepatitis E Virus ORF3 Protein Student (2016) (0)
[Hepatitis C: patient information]. (2015) (0)
S1 Raw images (2020) (0)
Cell-free expression, purification, and membrane reconstitution for NMR studies of the nonstructural protein 4B from hepatitis C virus (2016) (0)
HEV as a cause of acute hepatitis acquired in Switzerland (2017) (0)
86th annual congress of the Swiss Society of Pathology (2020) (0)
Determinants for Membrane Association of the HCV NS2 Protease Domain (2012) (0)
[Chronic hepatitis. 2: Treatment]. (2001) (0)
Age Above 60 Years Is Not a Negative Predictive Factor For Combined Antiviral Therapy With Pegylated Interferon Alpha and Ribavirin in Hepatitis C Patients (2012) (0)
The Membrane Anchor of GB virus B Nonstructural Protein 5B Can Substitute the Hepatitis C Virus NS5B Transmembrane Domain: Implications for a Conserved Protein Interaction Site (2010) (0)
Next-generation sequencing of Swiss HEV isolates allows for reconstitution of functional clones (2022) (0)
[Primary sclerosing cholangitis]. (1991) (0)
[Gene technology]. (1999) (0)
Sarcopenia assessed via computed tomography is associated with short-term outcomes and improves prognostic scores’ performance in critically ill patients with acute on chronic liver failure (2022) (0)
Structure and Function of the Membrane Anchor Domain of Hepatitis C Virus Nonstructural Protein 5A*□S (2004) (0)
[When and how to treat hepatitis B and C?]. (2005) (0)
[A primer on the management of antiviral resistance in chronic hepatitis B]. (2009) (0)
Hepatitis E Virus ORF3 Protein Forms Membrane-Associated Oligomers (2016) (0)
Efficacy of direct oral anticoagulants in plasma from patients with liver cirrhosis at high thrombotic risk (2021) (0)
[Alcoholic liver disease: another neglected disease?]. (2012) (0)
[Metabolism and therapeutic monitoring of azathioprine in gastroenterology and hepatology]. (2022) (0)
Reexamining the Role of the Humoral Immune Response in Control of Hepatitis C Virus Infection (2004) (0)
Case Report: SARS-CoV-2 as an unexpected causal agent of isolated febrile hepatitis (2021) (0)
Continuous human cell lines inducibly expressing the complete hepatitis C virus open reading frame (1997) (0)
Autochthonous hepatitis E as a cause of acute-on-chronic liver failure and death: histopathology can be misleading but transaminases may provide a clue. (2021) (0)
All-cause mortality and causes of death in the Swiss Hepatitis C Cohort Study (2019) (0)
Leonardo Complex Including a Candidate Viral Replication Induces Distinct Membrane Alterations Expression of Hepatitis C Virus Proteins (2002) (0)
In vitro efficacy of direct oral anticoagulants in plasma from patients with liver cirrhosis (2023) (0)
NMR structure of the membrane anchor domain (1-31) of the nonstructural protein 5A (NS5A) of hepatitis C virus (Minimized average structure, Sample in 100mM DPC) (2004) (0)
Hepatitis E Virus Seroprevalence and Chronic Infections in Patients with HIV , Switzerland KENFAK-FOGUENA (2019) (0)
[Dolly, Polly et al.: cloning by somatic cell nucleus transfer]. (1999) (0)
Cytokines and hepatitis C virus replication (2002) (0)
Inhibition of interferon alpha signalling through the JAK-STAT pathway in HCV transgenic mice (2001) (0)
P1309 HCV MUTANTS RESISTANT TO MACROCYCLIC NS3-4A PROTEASE INHIBITORS SUPPRESS INTERFERON-β INDUCTION BY EFFICIENT MAVS CLEAVAGE (2014) (0)
Specific inhibition of hepatitis C virus core antigen production by antisene RNA constructions (1995) (0)
381 Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes in living cells (2003) (0)
[Liver transplantation]. (2011) (0)
[Molecular models of disease. Transgenes and knockout]. (1997) (0)
N-terminal amphipathic alpha-helix 42-66 (AH2) plays a central role in the oligomerization of hepatitis C virus nonstructural protein 4B (2010) (0)
Chapter 10 – Molecular Pathogenesis of Hepatocellular Carcinoma (2006) (0)
Molekulare Krankheitsmodelle. Transgene und "knockout". [Molecular models of disease. Transgenes and knockout] (1997) (0)
Influence of geographical origin on access to therapy and therapy outcomes in hepatitis C virus-infected persons: the Swiss Hepatitis C Cohort Study (2018) (0)
Syndrome d’Alagille [Alagille Syndrome] (2019) (0)
[Therapy of hepatitis C]. (2002) (0)
P168 Primary sclerosing cholangitis in the Swiss IBD cohort study: prevalence, patient characteristics, and disease course (2013) (0)
[From Molecuar to Natural Medicine]. (2018) (0)
[Highlights in hepatology]. (2008) (0)
Body composition and short-term mortality in critically ill patients with acute on chronic liver failure (2023) (0)
[Hepatitis D: forgotten but not gone]. (2010) (0)
[New methods for demonstrating nucleic acids]. (2001) (0)
SAT-207-Rabbit HEV in immunosuppressed patients with hepatitis E acquired in Switzerland (2019) (0)
Tournament Sessions (2017) (0)
[Hepatitis C at a crossroads]. (2010) (0)
Self-Expanding Metal Stents in Patients with Cirrhosis and Severe or Refractory Esophagealvariceal Bleeding: A Systematic Review and Meta-Analysis (2016) (0)
HBV-HCV Coinfection: Insights from a Novel Model System (2008) (0)
Akute und chronische Hepatitis E (2017) (0)
Randomisierte, kontrollierte Studie zur Wirksamkeit von PegIFN-alpha 2a + Plasmaspiegel-adaptiertem Ribavirin vs. PegIFN-alpha 2a + gewichts-basiertem Ribavirin bei chronischer Hepatitis C Genotyp 1 (2011) (0)
Therapie der Hepatitis C (2002) (0)
Molekularbiologie in der Inneren Medizin: Bericht über das 24.Ludwig-Heilmeyer-Symposium der Gesellschaft für Fortschritte in der Inneren Medizin (2008) (0)
Hepatitis C: Information für Patienten (2015) (0)
Von der molekularen Medizin bis zur Naturheilkunde (2018) (0)
[Chronic hepatitis. 1: Diagnosis]. (2001) (0)
Neues aus der Hepatologie (2011) (0)
[Hepatitis C]. (2004) (0)
Hepatitis-C-Therapie bei Drogenpatienten - Replik (2005) (0)
[Chronic hepatitis. 3. An actual case]. (2001) (0)
Pilotstudie zur Bedeutung von Mutationen der Hepatitis C Virus 1b “Interferon Sensitivity Determining Region” (NS5A aa 2209–2248) für das Ansprechen auf Interferon-α bei Patienten mit chronischer Hepatitis (1999) (0)
Molekulare Krankheitsmodelle – Transgene und «knockout» (2009) (0)
Oesophagite a eosinophiles: mise a jour 2011. (2011) (0)
ER Folgen des Alkohols (2002) (0)
Effiziente MAVS-Spaltung und Suppression der Interferon-β-Induktion durch HCV-Varianten mit Resistenzen gegen makrozyklische NS3-4A Protease-Inhibitoren (2014) (0)
[Eosinophilic esophagitis: update 2011]. (2011) (0)
Hepatologie: Wichtiges zur chronischen Hepatitis C (2013) (0)
Hauptthema: Benigne und maligne Gallenwegstenosen (1999) (0)
[Viral hepatitis]. (2011) (0)
A picture says more than a thousand words: Structural insights into hepatitis C virus translation initiation (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Darius Moradpour?

Darius Moradpour is affiliated with the following schools:

Darius Moradpour's Academic­Influence.com Rankings

Darius Moradpour's Degrees

Similar Degrees You Can Earn

Why Is Darius Moradpour Influential?

Darius Moradpour's Published Works

Published Works

What Schools Are Affiliated With Darius Moradpour?

Darius Moradpour's AcademicInfluence.com Rankings